Return to homepagePandemic Pact

Harnessing antiviral antibodies for pandemic preparedness

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA353553

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2024
    2028

  • Known Financial Commitments (USD)

    $408,536.67

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVID-19 pandemic emphasised the crucial role of antibodies in preventing and treating viral infections via vaccination or antiviral drugs. This project will enhance our comprehension of how antibodies contribute to antiviral immunity and develop innovative antibody therapeutics against emerging pandemic viruses. The knowledge gained will improve antibody drug manufacturing and delivery methods, enhancing preparedness against future pandemics.